1-3 of 3
Karen Keating
Close
Sort by
Journal Articles

Effect of COVID-19 Pandemic Control Measures on Diagnoses of Hematologic Cancer Among CMS Population in 2020

Dave Smart, Wendy Moore, Karina Hjort, Karen Keating, Bob Holt, Raymond Henderson, Peter Riccelli, Kenneth Bloom, Anthony Magliocco, Curtis A. Hanson
Journal: Blood
Blood (2021) 138 (Supplement 1): 5017.
https://doi.org/10.1182/blood-2021-153005
Published: 2021
Journal Articles

What Are the Most Important Symptoms and Concerns of Patients with Indolent Non-Hodgkin's Lymphoma? Content Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy Lymphoma Symptom Index-18 (NFLymSI-18)

Karen Kaiser, PhD, Sara Shaunfield, PhD, Kimberly Webster, MA, Karen Keating, MBA, Lara Boyken, Sara Duffey, Jessica Yarber, MD, David Cella, PhD
Journal: Blood
Blood (2016) 128 (22): 4792.
https://doi.org/10.1182/blood.V128.22.4792.4792
Published: 2016
Journal Articles

Preclinical and Clinical Pharmacodynamics of Pan-Pim Inhibition By AZD1208 in Acute Myeloid Leukemia: Assessment of Pim Isoform Dependency for Bad and 4EBP1 Phosphorylation

Kristen A McEachern, PhD, Adriana E Tron, PhD, Greg O'Connor, Rachel DuPont, Francis D Gibbons, PhD, Lourdes Pablo, Karthick Vishwanathan, PhD, Patricia McCoon, PhD, Jorge E. Cortes, MD, Daniel J. DeAngelo, MDPhD, Mark D Minden, MDPhD, Geoffrey L. Uy, MD, Frank Neumann, MDPhD, Karen Keating, Dennis Huszar, PhD, J. Elizabeth Pease, PhD, Jeffrey Brown, PhD, J. Carl Barrett, PhD
Journal: Blood
Blood (2014) 124 (21): 906.
https://doi.org/10.1182/blood.V124.21.906.906
Published: 2014